Loading...
Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of poorly differentiated non-small-cell lung cancer (NSCLC), and no effective treatment is available in clinical practice currently. In the present report, a 61-year-old male patient was hospitalized due to cough, dyspnea, and right chest pain....
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501700/ https://ncbi.nlm.nih.gov/pubmed/31118683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S196751 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|